These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29746408)

  • 21. Quantification of retinal microvasculature and neurodegeneration changes in branch retinal vein occlusion after resolution of cystoid macular edema on optical coherence tomography angiography.
    Brar M; Sharma M; Grewal SPS; Grewal DS
    Indian J Ophthalmol; 2019 Nov; 67(11):1864-1869. PubMed ID: 31638051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.
    Callizo J; Atili A; Striebe NA; Bemme S; Feltgen N; Hoerauf H; Bertelmann T
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):913-920. PubMed ID: 30610424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections.
    Osaka R; Muraoka Y; Miwa Y; Manabe K; Kobayashi M; Takasago Y; Ooto S; Murakami T; Suzuma K; Iida Y; Tsujikawa A
    Ophthalmologica; 2018; 239(1):27-35. PubMed ID: 28946138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of Underlying Pathologies of Macular Edema Using Spectral Domain Optical Coherence Tomography (SD-OCT).
    Dysli M; Rückert R; Munk MR
    Ocul Immunol Inflamm; 2019; 27(3):474-483. PubMed ID: 31184556
    [No Abstract]   [Full Text] [Related]  

  • 26. Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.
    Khurana RN; Chang LK; Bansal AS; Palmer JD; Wu C; Wieland MR
    Ophthalmol Retina; 2018 Feb; 2(2):128-133. PubMed ID: 31047339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
    Zhang HR; Wang X; Lu XR; Yang YF; Liu F
    Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease of the Year: Differential Diagnosis of Uveitic Macular Edema.
    Agarwal A; Pichi F; Invernizzi A; Gupta V
    Ocul Immunol Inflamm; 2019; 27(1):72-88. PubMed ID: 30273513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cystoid macular edema using optical coherence tomography and fundus fluorescein angiography after uncomplicated phacoemulsification surgery.
    Kusbeci T; Eryigit L; Yavas G; Inan UU
    Curr Eye Res; 2012 Apr; 37(4):327-33. PubMed ID: 22440164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical coherence tomography (OCT) in macular edema.
    Brancato R
    Doc Ophthalmol; 1999; 97(3-4):337-9. PubMed ID: 10896348
    [No Abstract]   [Full Text] [Related]  

  • 31. Patterns of Macular Edema in Uveitis as Diagnosed by Optical Coherence Tomography in Tertiary Eye Center.
    Gupta S; Shah DN; Joshi SN; Aryal M; Puri LR
    Nepal J Ophthalmol; 2018 Jan; 10(19):39-46. PubMed ID: 31056575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusion.
    Sohn JH; Song SJ
    Korean J Ophthalmol; 2006 Dec; 20(4):210-4. PubMed ID: 17302205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and Therapeutic Challenges.
    Tripathy K; Aleman TS
    Retina; 2019 Oct; 39(10):2053-2058. PubMed ID: 30074523
    [No Abstract]   [Full Text] [Related]  

  • 34. CLINICAL FINDINGS OF EYES WITH MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION REFRACTORY TO RANIBIZUMAB.
    Hasegawa T; Kawano T; Maruko I; Koizumi H; Iida T
    Retina; 2018 Jul; 38(7):1347-1353. PubMed ID: 28492435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ANGIOGRAPHIC RISK FACTORS FOR RECURRENCE OF MACULAR EDEMA ASSOCIATED WITH BRANCH RETINAL VEIN OCCLUSION.
    Kogo T; Muraoka Y; Uji A; Ooto S; Murakami T; Kadomoto S; Iida-Miwa Y; Miyake M; Miyata M; Tsujikawa A
    Retina; 2021 Jun; 41(6):1219-1226. PubMed ID: 33323902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macular Telangiectasia Type 1 Managed With Long-Term Aflibercept Therapy.
    Kovach JL; Hess H; Rosenfeld PJ
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6):593-5. PubMed ID: 27327292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macular edema in retinal vein occlusion: up-date from the central retinal vein occlusion study.
    Soubrane G
    Doc Ophthalmol; 1999; 97(3-4):279-81. PubMed ID: 10896341
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion.
    Son BK; Kwak HW; Kim ES; Yu SY
    Korean J Ophthalmol; 2017 Jun; 31(3):209-216. PubMed ID: 28471106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and Therapeutic Challenges.
    Khundkar T; Johnson B; Mehta S
    Retina; 2020 Feb; 40(2):387-390. PubMed ID: 31972810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.